U.S. Regulators Want Additional Divestitures, but Bayer-Monsanto Deal Will Probably Still Close
On March 15, Bloomberg reported that the U.S. Justice Department’s antitrust division wants further divestitures from either Bayer or Monsanto before approving the merger. The market reacted negatively to the news, sending Monsanto’s share price down roughly 4% to $118 per share, and Bayer shares were down nearly 1% to EUR 95 per share at the time of writing. While some additional divestitures will likely be required, we ultimately think Bayer and Monsanto will be able to work out a deal to win ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.